{
    "organizations": [],
    "uuid": "c7dfcea46fd8db4807ab3b3e76926a766835f217",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-miragen-therapeutics-reports-q1-lo/brief-miragen-therapeutics-reports-q1-loss-per-share-0-18-idUSASC0A13I",
    "ord_in_thread": 0,
    "title": "BRIEF-Miragen Therapeutics Reports Q1 Loss Per Share $0.18",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - miRagen Therapeutics Inc:\n* MIRAGEN THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* Q1 REVENUE VIEW $1.2 MILLION — THOMSON REUTERS I/B/E/S * Q1 EARNINGS PER SHARE VIEW $-0.24 — THOMSON REUTERS I/B/E/S\n* CASH AND CASH EQUIVALENTS AT MARCH 31, 2018 WERE $78.1 MILLION, COMPARED TO $47.4 MILLION AT DECEMBER 31, 2017 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T04:17:00.000+03:00",
    "crawled": "2018-05-10T17:49:48.029+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "miragen",
        "therapeutic",
        "inc",
        "miragen",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q1",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "cash",
        "cash",
        "equivalent",
        "march",
        "million",
        "compared",
        "million",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}